SCHEMBL2556823

SCHEMBL2556823

CC(C)(C)CCOCCOCC(O[SiH](c1ccccc1)c1ccccc1)C(=O)O

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 3/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RIPK1 Q13546 1/20 0.31
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31
GAA P10253 2/20 0.31
SRR Q9GZT4 2/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
MEN1 O00255 1/20 0.30
MAPT P10636 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8071089 0.82 EDNRB (0.33) EDNRBEDNRAALDH1A1KDM4ELMNA
SCHEMBL8070835 0.82 EDNRB (0.33) EDNRBEDNRAALDH1A1KDM4ELMNA
SCHEMBL9523641 0.72 PPARG (0.33) ALDH1A1KDM4ERIPK1PPARGPPARA
SCHEMBL9115858 0.71 PPARG (0.32) PPARGPPARASRR
SCHEMBL8075407 0.71 PPARA (0.36) EDNRBEDNRAALDH1A1KDM4ERIPK1
SCHEMBL8070765 0.70 PPARA (0.33) EDNRBEDNRAALDH1A1KDM4ERIPK1
SCHEMBL9123975 0.68 TSHR (0.32) PPARGPPARASRRMEN1KMT2A
SCHEMBL9123988 0.68 TSHR (0.32) PPARGPPARASRRMEN1KMT2A
SCHEMBL708400 0.67 RIPK1 (0.37) RIPK1MAPK1
SCHEMBL927306 0.67 SMN1; SMN2 (0.33) KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4029510-A1 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS Kodiak Sciences Inc. (US) 2022-07-20 EP disclosed
EP-3549963-B1 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS KODIAK SCIENCES INC (US) 2022-01-12 EP disclosed
US-20210402015-A1 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS KODIAK SCIENCES INC (US) 2021-12-30 US disclosed
US-20200171179-A1 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS KODIAK SCIENCES INC. 2020-06-04 US disclosed
EP-3549963-A2 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS Kodiak Sciences Inc. (US) 2019-10-09 EP disclosed
EP-2558538-B1 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS KODIAK SCIENCES INC (US) 2019-07-03 EP disclosed
US-20170143841-A1 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS KODIAK SCIENCES INC. 2017-05-25 US disclosed
US-20140024776-A1 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS OLIGASIS (US) 2014-01-23 US disclosed
EP-2558538-A2 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS Oligasis (US) 2013-02-20 EP disclosed
WO-2011130694-A2 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS OLIGASIS (US) 2011-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170143841-A1 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS ACP1, PHOSPHO1, PARG EDNRB 3403/4885EDNRA 2612/4885ALDH1A1 4348/4885
US-20140024776-A1 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS ACP1, PHOSPHO1, PARG EDNRB 3403/4885EDNRA 2612/4885ALDH1A1 4348/4885
US-20200171179-A1 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS ACP1, PHOSPHO1, PARG EDNRB 3403/4885EDNRA 2612/4885ALDH1A1 4348/4885
US-20210402015-A1 HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS ACP1, PHOSPHO1, PARG EDNRB 3403/4885EDNRA 2612/4885ALDH1A1 4348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.